Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Bromfenac products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 26, 2027.
Anti-inflammatory eye drops used to reduce inflammation and pain after eye surgery.
Products affected
1 / 2
In shortage since
Jul 8, 2025
Est. full return
Mar 26, 2027
Reports on file
12
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · since Jul 8, 2025, est. end Mar 26, 2027 · Disruption of the manufacture of the drug.
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jan 5, 2026 · Demand increase for the drug.
Resolved
APO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · ended Jan 4, 2024 · Disruption of the manufacture of the drug.
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jan 11, 2023 · Shortage of an active ingredient.
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Oct 27, 2022 · Shortage of an inactive ingredient or component.
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jul 15, 2022 · Delay in shipping of the drug.
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Nov 5, 2018
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Aug 21, 2018
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jun 15, 2018
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Mar 1, 2017
Resolved
PROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jun 9, 2017 · production delay
What's happening
Bromfenac is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bromfenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).
Recent changes
No changes recorded yet.
Common questions
What is Bromfenac used for?
Anti-inflammatory eye drops used to reduce inflammation and pain after eye surgery.
When will Bromfenac be back in stock in Canada?
The latest manufacturer estimate is Mar 26, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Bromfenac in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.